Determinants of Risk Infection During Therapy with Anti TNF-Alpha Blocking Agents in Rheumatoid Arthritis

por Benucci, M, Saviola, G, Baiardi, P, Manfredi, M, Sarzi Puttini, P, Atzeni, Fabiola
Publicado 2012

Highlights on Novel Technologies for the Detection of Antibodies to Ro60, Ro52, and SS-B

por Infantino, M., Bentow, C., Seaman, A., Benucci, M., Atzeni, F., Sarzi-Puttini, P., Olivito, B., Meacci, F., Manfredi, M., Mahler, M.
Publicado 2013

Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, co...

por Emery, P, Gottenberg, J E, Rubbert-Roth, A, Sarzi-Puttini, P, Choquette, D, Taboada, V M Martínez, Barile-Fabris, L, Moots, R J, Ostor, A, Andrianakos, A, Gemmen, E, Mpofu, C, Chung, C, Gylvin, L Hinsch, Finckh, A
Publicado 2015